Moreover, METTL3 expression is upregulated in ovarian cancer and is associated with advanced tumor grades and stages, lymph node and distant metastases, the International Federation of Gynecology and Obstetrics stage, and overall patient survival. Here, METTL3 is linked to neoplasm.